Bullish Gator

Edwards Lifesciences (EW)

Technical, fundamental, and sentiment analysis with recent related videos.

Stock Hub•Last Updated: 2026-11-21

Bullish Gator Rating
Bullish

EW rates Bullish overall. The fundamental read is bullish: the company passes 6 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 13.09); revenue grew an average of 10.8% a year over the last three fiscal years; net income grew an average of 38.5% a year over the same period. The technical picture is bullish: price is 17.2% above the 200-day moving average; 10.4% above the 50-day; the 50-day moving average sits above the 200-day (Golden cross state). Sentiment is bullish (composite 79/100), based on 6 news articles from recent coverage.

Fundamental Rating
Bullish

Revenue 3-year avg +10.8%. Net income 3-year avg +38.5%.

Technical Rating
Bullish

Price vs 20DMA +1.8%. RSI 59.21. Bollinger state: Inside Bands.

Sentiment Rating
Bullish

Composite score 79/100 from the AI judge, based on 6 news items, 0 television segments, and 0 videos.

Latest Market Read

All three badges line up Bullish. The Fundamental badge reflects a 3-year average annual revenue gain of 10.8 percent and net income averaging 38.5 percent per year, alongside the usual Piotroski F-Score and Altman Z-Score inputs. The Technical badge leans bullish with price 1.8 percent above its 20-day moving average (20-day moving average), the Relative Strength Index (RSI), a momentum reading, at 59.2, and the stock trading inside its Bollinger Bands. Sentiment sits at 79/100, Bullish, which matches the other two and yields an overall Bullish rating.

Recent news: The coverage is broadly positive: Edwards reported strong Q3 results with $1,715.5M in sales and $307.5M net income, raised full‑year guidance and gave a Q4 sales range, while highlighting strong PASCAL and PROGRESS TAVR data. The company also secured a $750M five‑year revolver to boost liquidity, and MarketBeat shows a consensus 'Moderate Buy' from 26 analysts; minor negatives such as a $220.2M impairment and a small institutional stake reduction were noted but do not outweigh the upbeat results and guidance. Sources largely agree on the constructive fundamentals, and the GDELT tone (55) modestly supports that view.

Latest Videos

  • No qualified videos yet.